Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Amortization of Deferred Charges (2019 - 2021)

Usana Health Sciences (USNA) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $2.2 million as the latest value for Q4 2021.

  • Quarterly Amortization of Deferred Charges rose 5.51% to $2.2 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Oct 2021, up 4.78% year-over-year, with the annual reading at $8.8 million for FY2021, 6.03% up from the prior year.
  • Amortization of Deferred Charges for Q4 2021 was $2.2 million at Usana Health Sciences, down from $2.3 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $2.3 million in Q1 2021, with the low at $2.0 million in Q2 2019.
  • Average Amortization of Deferred Charges over 3 years is $2.2 million, with a median of $2.2 million recorded in 2019.
  • The sharpest move saw Amortization of Deferred Charges increased 11.47% in 2020, then grew 0.18% in 2021.
  • Over 3 years, Amortization of Deferred Charges stood at $2.2 million in 2019, then dropped by 2.07% to $2.1 million in 2020, then increased by 5.51% to $2.2 million in 2021.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $2.2 million, $2.3 million, and $2.3 million for Q4 2021, Q3 2021, and Q2 2021 respectively.